YK

Yogendra Kumar Gupta

Active Director Director DIN 03432845
DIN 03432845 First appointment Oct 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Oct 2010
Shareholding value •••• Premium profile

About Yogendra Kumar Gupta

Data last updated:

Yogendra Kumar Gupta is a Director at Cliantha Research Limited (since 2024), Director at Bharat Immunologicals And Biologicals Corporation Limited (since 2010) and Director at Foundation For Disease Elimination And Control Of India (since 2018), and holds 2 more current directorships. The companies operate in Pharma and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹861 Cr; the largest is Cliantha Research Limited at ₹782 Cr (FY 2026).

DIN 03432845
Primary Designation Director
Industry Pharma
First Appointment 26 Oct 2010
Oldest Company Age 37 yrs
Largest company Cliantha Research Limited · ₹782 Cr (FY 2026)
Combined revenue ₹861 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cliantha Research Limited U73100GJ2004PLC044669
Director05 Sep 20242004₹782 Cr (FY 2026)Active
Director26 Oct 20101989₹79.49 Cr (FY 2022)Active
Director04 Aug 20182016₹13.4 Lakh (FY 2025)Active
Director01 Mar 20242018₹8,800 (FY 2024)Active
Designated Partner16 Oct 20202020Active

Directorship timeline

Open interactive timeline →
Vatyka Health Vision Llp
Bharat Immunologicals And Biologicals Corporation Limited
Foundation For Disease Elimination And Control Of India
Sicuremi Healthcare Technologies Private Limited
Premium access

Shareholding and investment profile for Yogendra Kumar Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogendra Kumar Gupta

Yogendra Kumar Gupta currently holds 5 directorships: Cliantha Research Limited (Director, since 05 Sep 2024, revenue ₹782 Cr (FY 2026)); Bharat Immunologicals And Biologicals Corporation Limited (Director, since 26 Oct 2010, revenue ₹79.49 Cr (FY 2022)); Foundation For Disease Elimination And Control Of India (Director, since 04 Aug 2018, revenue ₹13.4 Lakh (FY 2025)); Sicuremi Healthcare Technologies Private Limited (Director, since 01 Mar 2024, revenue ₹8,800 (FY 2024)); Vatyka Health Vision Llp (Designated Partner, since 16 Oct 2020).

Yogendra Kumar Gupta was first appointed on 26 Oct 2010 as Director at Bharat Immunologicals And Biologicals Corporation Limited. The most recent appointment on record is 05 Sep 2024 at Cliantha Research Limited.

The 4 current companies of Yogendra Kumar Gupta that report revenue have a combined latest revenue of ₹861 Cr: Cliantha Research Limited ₹782 Cr (FY 2026); Bharat Immunologicals And Biologicals Corporation Limited ₹79.49 Cr (FY 2022); Foundation For Disease Elimination And Control Of India ₹13.4 Lakh (FY 2025); Sicuremi Healthcare Technologies Private Limited ₹8,800 (FY 2024).

The current boards of Yogendra Kumar Gupta's companies include Manubhai Khodidas Patel (Cliantha Research Limited), Naveen Sharma (Cliantha Research Limited), Naveen Sharma (Cliantha Research Limited), Nilima Arun Kshirsagar (Cliantha Research Limited), Rajiv Vikrambhai Kamani (Cliantha Research Limited), Alka Sharma (Bharat Immunologicals And Biologicals Corporation Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available